Globalisation of clinical trials in oncology: a double-edged sword?
-
Published:2023-09
Issue:1
Volume:2
Page:e000163
-
ISSN:2752-7948
-
Container-title:BMJ Oncology
-
language:en
-
Short-container-title:bmjonc
Author:
Jenei KristinaORCID,
Moraes Fabio Y,
Gyawali BishalORCID
Reference11 articles.
1. Payedimarri AB , Mouhssine S , Aljadeeah S , et al . Globalization of industry-sponsored clinical trials for breast, lung, and colon cancer research: trends, threats, and opportunities. BMJ Oncology 2023. doi:10.1136/bmjonc-2023-000101
2. Randomized controlled trials in lung, gastrointestinal, and breast cancers: an overview of global research activity;Wells;Curr Oncol,2022
3. Stensland KD , McBride RB , Latif A , et al . Adult cancer clinical trials that fail to complete: an epidemic JNCI 2014;106. doi:10.1093/jnci/dju229
4. Clinical Trials Disrupted During War in Ukraine
5. Gyawali B , Carson LM , Berry S , et al . Challenges of globalization of cancer drug Trials- recruitment in Lmics, approval in Hics. Lancet Reg Health Am 2022;7:100157. doi:10.1016/j.lana.2021.100157